510(k) K250105
K250105 is an FDA 510(k) premarket notification submitted by Aveera Medical, Inc. for the device "Boomerang Valvulotome (BMGVT080); Boomerang Push Valvulotome (BMGPVT125)". The FDA issued a decision of Substantially Equivalent on July 3, 2025. The device falls under product code MGZ (Valvulotome), a Class II device regulated under 21 CFR 870.4885.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 3, 2025
- Date Received
- January 15, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Valvulotome
- Device Class
- Class II
- Regulation Number
- 870.4885
- Review Panel
- CV
- Submission Type